Tags:DevelopmentFinTechFutureHealthTechITPlatformPublicResearchScience
CEPI is an innovative partnership between public, private, philanthropic, and civil organisations, launched at Davos in 2017, to develop vaccines against future epidemics. Prior to COVID-19, CEPI’s work focused on developing vaccines against the Ebola Virus Disease, Lassa virus, Middle East Respiratory Syndrome coronavirus, Nipah virus, Rift Valley Fever virus and Chikungunya virus. It has over 20 vaccine candidates against these pathogens in development. CEPI has also invested in new platform technologies for rapid vaccine development against unknown pathogens (Disease X). During the current pandemic, CEPI initiated multiple programmes to develop vaccines against SARS-CoV-2 and its variants with a focus on speed, scale, and access. These programmes leverage the rapid response platforms developed by CEPI’s partners prior to the emergence of COVID-19, as well as new collaborations. The aim is to advance clinical development of a diverse portfolio of safe and effective COVID-19 candidates and to enable fair allocation of these vaccines worldwide through COVAX. CEPI’s 5-year plan lays out a $3.5 billion roadmap to compress vaccine development timelines to 100 days, develop a broadly protective vaccine against COVID-19 and other Betacoronaviruses, and create a “library” of vaccine candidates for use against known and unknown pathogens. The plan is available at www.endpandemics.cepi.net
Location: Norway, Oslo
Member count: 201-500
Total raised: $1.598316816B
Founded date: 2017

Funding Rounds 2

DateSeriesAmountInvestorsDeal News
18.10.2022-$98.316816...-bio-m.org/...
08.03.2022-$1.5B--

Mentions in press and media 48

DateTitleDescriptionCategoryAuthorSource
11.01.2023Another Eb...When I learned that an outbrea...--statnews.c...
30.11.2022Epidemic C...April Fowell, Tech Times 30 No...--techtimes....
25.10.2022SK bioscie...CEPI supports up to 40 mil. US...--en.prnasia...
18.10.2022CEPI recei...The German Federal Ministry of...--bio-m.org/...
15.05.2022Bill Gates...The WHO estimates that the Cov...--vox.com/re...
25.02.2022Japan, UK ...As Covid-19 nears its inevitab...-Kyle Blank...endpts.com...
02.02.2022Valneva : ...Valneva Announces Initiation o...--marketscre...
17.11.2021With 128 C...Pfizer/BioNTech. Moderna. John...--statnews.c...
22.09.2021Clover's C...Trial enrolled over 30,000 adu...--en.prnasia...
23.07.2021Plague Inc...‘In Plague Inc, the Olympics h...--businessin...
Show more